By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Nanobiotix SA is a late-stage clinical company engaged in developing and selling nanomedicine for the treatment of cancer. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. The company's products include NBTXR3, a preclinical research program for cancer immunotherapies.

Contact Information

Website: www.nanobiotix.com
Main Phone: +33 140260470
Address: 60, Rue de Wattignies
City / Town: Paris
Country: FR
Postal Code: 75012

Issuer Information

Exchange: NGS
CEO: Laurent Levy
Employees: 98

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A